Bayer Contests Generics' Loss Claims In Xarelto Patent Fight
By Jamie Lennox ( June 5, 2025, 3:58 PM BST) -- Bayer has accused several generic-drug makers of overstating the profits they lost when a judge in London told them to stop selling their own versions of blood thinner Xarelto to avoid infringing a patent that the courts later invalidated....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.